Sophie hopes the drug could give her more time with daughter Maya (Image: Sophie Blake) A wonder drug denied to thousands of women in England with incurable breast cancer cuts the risk of the disease spreading by more than a third, a study suggests. Findings presented at the world’s largest cancer conference have added fuel to the fire for campaigners who are demanding that health chiefs and manufacturers strike a deal. Sophie Blake, 51, is among patients desperate to access the drug, Enhertu.
She was diagnosed with breast cancer in December 2020 and received the devastating news that it had become terminal in May 2022. She said: “This is yet more evidence of the precious extra time this treatment could give us. function loadOvpScript(){let el=document.
createElement('script');el.setAttribute('src','https://live.primis.
tech/live/liveView.php?s=114945&playerApiId=v114945');document.getElementById('ovp-primis').
appendChild(el)}window.top.addEventListener('primisPlayerInit',e=>{try{if(e.
detail&&e.detail.playerApiId==="v114945"){if(window.
document.getElementsByClassName('jwplayer')[0]){e.detail.
float('disable')}}}catch(e){}});window.addEventListener('DOMContentLoaded',()=>{setTimeout(()=>{if(typeof flagTcfLoaded!=='undefined'&&flagTcfLoaded===!0){loadOvpScript()ExpressApp.Log('[Load] OVP flagTcfLoaded',new Date())}else{document.
addEventListener("tcfLoaded",()=>{loadOvpScript()ExpressApp.Log('[Load] OVP tcfLoaded',new Date())})}},1500)}) “These wonder drugs are everything. I .
